Companies: 10,795·Total market cap: $144.5T
Prime Medicine, Inc.

Prime Medicine, Inc.

PRMENASDAQHealthcare● Active
$2.96
$-0.10(-3.27%)
Market Cap$534627652
P/E Ratio—
52W High$6.94
52W Low$1.305
Overview

Prime Medicine, Inc. (PRME) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001894562 · PRME · NASDAQ · as of Jun 8, 2026

Filing snapshot

287
Total Filings
10-Q
Latest Form
2026-05-07
Most Recent
2022
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001894562 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-03
Fiscal Year End
Mar 3, 2026
Accession No.
0001628280-26-013569
Primary Document
prme-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001894562 · Accession 0001628280-26-013569

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-07
View 10-Q on SEC
8-KCurrent Report
8-K
2026-05-07Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
10-QQuarterly Report
10-Q
2026-05-07
View
8-KCurrent Report
8-K
2026-05-07
View
ARSARS
ARS
2026-04-23
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-23
View
DEF 14AProxy Statement
DEF 14A
2026-04-23
View
3Initial Statement of Beneficial Ownership
FORM 3
2026-04-17
View
8-KCurrent Report
8-K
2026-04-16
View
EFFECTEFFECT
EFFECT
2026-03-04
View
S-8Employee Stock Plan Registration
S-8
2026-03-03
View
POS AMPOS AM
POS AM
2026-03-03
View
10-KAnnual Report
10-K
2026-03-03
View
POSASRPOSASR
POSASR
2026-03-03
View
8-KCurrent Report
8-K
2026-03-03
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-17
View
8-KCurrent Report
8-K
2026-01-12
View
Showing 1–15 of 169 filingsForm 4 / 144 hidden· 287 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001894562  |  Exchange: NASDAQ · Healthcare

Prime Medicine, Inc. (NASDAQ: PRME) has submitted 287 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2022. As a Healthcare sector company with CIK 0001894562, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Prime Medicine, Inc.'s most comprehensive regulatory disclosure. The most recent Prime Medicine, Inc. 10-K was filed on 2026-03-03 for fiscal year ending 2026. Historical PRME 10-K annual reports are available from 2021 through 2026.

Investors researching Prime Medicine, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
TYRA SEC Filings →VIR SEC Filings →SEPN SEC Filings →BCAX SEC Filings →EYPT SEC Filings →KURA SEC Filings →REPL SEC Filings →MRVI SEC Filings →
→ PRME Financials→ PRME Earnings→ PRME Insider Trades

Frequently Asked Questions

PRME SEC Filings · 8 questions

Prime Medicine, Inc. (PRME) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 287 filings and access original documents at no cost. Prime Medicine, Inc.'s CIK is 0001894562.

PRME SEC filingsPrime Medicine, Inc. SEC documentsfind PRME 10-K